These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7871019)

  • 1. Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.
    Woods A; Smith C; Szewczak M; Dunn RW; Cornfeldt M; Corbett R
    Psychopharmacology (Berl); 1993; 112(2-3):195-8. PubMed ID: 7871019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Besipirdine (HP 749) reduces schedule-induced polydipsia in rats.
    Woods-Kettelberger AT; Smith CP; Corbett R; Szewczak MR; Roehr JE; Bores GM; Klein JT; Kongsamut S
    Brain Res Bull; 1996; 41(2):125-30. PubMed ID: 8879677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam.
    Joel D; Ben-Amir E; Doljansky J; Flaisher S
    Behav Pharmacol; 2004 May; 15(3):241-52. PubMed ID: 15187582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
    Kreiss DS; Coffman CF; Fiacco NR; Granger JC; Helton BM; Jackson JC; Kim LV; Mistry RS; Mizer TM; Palmer LV; Vacca JA; Winkler SS; Zimmer BA
    Pharmacol Biochem Behav; 2013 Mar; 104():119-24. PubMed ID: 23333679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in paroxetine binding in the cerebral cortex of polydipsic rats.
    Roehr J; Woods A; Corbett R; Kongsamut S
    Eur J Pharmacol; 1995 May; 278(1):75-8. PubMed ID: 7664815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology.
    Tsaltas E; Kontis D; Chrysikakou S; Giannou H; Biba A; Pallidi S; Christodoulou A; Maillis A; Rabavilas A
    Biol Psychiatry; 2005 May; 57(10):1176-85. PubMed ID: 15866558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder?
    Joel D; Avisar A
    Behav Brain Res; 2001 Aug; 123(1):77-87. PubMed ID: 11377731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schedule-induced polydipsia: a rat model of obsessive-compulsive disorder.
    Platt B; Beyer CE; Schechter LE; Rosenzweig-Lipson S
    Curr Protoc Neurosci; 2008 Apr; Chapter 9():Unit 9.27. PubMed ID: 18428677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
    De Carolis L; Schepisi C; Milella MS; Nencini P
    Psychopharmacology (Berl); 2011 Dec; 218(4):749-59. PubMed ID: 21660444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased amygdala and decreased hippocampus volume after schedule-induced polydipsia in high drinker compulsive rats.
    Mora S; Merchán A; Aznar S; Flores P; Moreno M
    Behav Brain Res; 2020 Jul; 390():112592. PubMed ID: 32417273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder.
    Dell'Osso B; Allen A; Hollander E
    Expert Opin Pharmacother; 2005 Dec; 6(15):2727-40. PubMed ID: 16316311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.
    Shanahan NA; Velez LP; Masten VL; Dulawa SC
    Biol Psychiatry; 2011 Dec; 70(11):1039-48. PubMed ID: 21920503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor inhibitory control and neurochemical differences in high compulsive drinker rats selected by schedule-induced polydipsia.
    Moreno M; Gutiérrez-Ferre VE; Ruedas L; Campa L; Suñol C; Flores P
    Psychopharmacology (Berl); 2012 Jan; 219(2):661-72. PubMed ID: 22113449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
    Kontis D; Boulougouris V; Papakosta VM; Kalogerakou S; Papadopoulos S; Poulopoulou C; Papadimitriou GN; Tsaltas E
    Psychopharmacology (Berl); 2008 Nov; 200(4):597-610. PubMed ID: 18622751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule-induced polydipsia as a model of compulsive behavior: neuropharmacological and neuroendocrine bases.
    Moreno M; Flores P
    Psychopharmacology (Berl); 2012 Jan; 219(2):647-59. PubMed ID: 22113447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic therapy of obsessive compulsive disorder.
    DeVeaugh-Geiss J
    Adv Pharmacol; 1994; 30():35-52. PubMed ID: 7833296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of drugs on the temporal distribution of schedule-induced polydipsia in rats.
    Pellon R; Blackman DE
    Pharmacol Biochem Behav; 1992 Nov; 43(3):689-95. PubMed ID: 1448466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin-dependent flank marking in golden hamsters is suppressed by drugs used in the treatment of obsessive-compulsive disorder.
    Ferris CF; Rasmussen MF; Messenger T; Koppel G
    BMC Neurosci; 2001; 2():10. PubMed ID: 11545675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.